Yarger Wealth Strategies LLC Has $308,000 Position in Cardinal Health, Inc. $CAH

Yarger Wealth Strategies LLC increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,835 shares of the company’s stock after acquiring an additional 76 shares during the quarter. Yarger Wealth Strategies LLC’s holdings in Cardinal Health were worth $308,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CAH. Wellington Management Group LLP increased its holdings in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI boosted its stake in Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after purchasing an additional 927,950 shares during the period. Nuveen LLC bought a new stake in Cardinal Health in the 1st quarter valued at $106,065,000. Finally, T. Rowe Price Investment Management Inc. bought a new stake in Cardinal Health in the 1st quarter valued at $104,951,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

NYSE:CAH opened at $156.86 on Monday. The stock has a fifty day moving average price of $152.09 and a 200-day moving average price of $151.31. The company has a market cap of $37.27 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a fifty-two week low of $106.98 and a fifty-two week high of $168.44.

Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is presently 31.63%.

Insider Activity

In other news, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CAH. Leerink Partners boosted their price target on Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Wells Fargo & Company restated an “overweight” rating and issued a $185.00 price target (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. UBS Group restated a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Evercore ISI reduced their price target on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.